Samuel Backenroth Insider Profile
4 Followers
Samuel Backenroth, Chief Financial Officer at Notable Labs, holds 525.00K shares in Notable Labs (Ticker: NTBLQ), holds 11.63K shares in NeuBase Therapeutics (Ticker: NBSE).
Samuel Backenroth's Trading History
| NTBLQNotable Labs | Apr 18, 2023 | Chief Financial Officer | Uninformative Buy | 87.67K | ― | |
| NBSENeuBase Therapeutics | May 04, 2020 | ― | Informative Buy | 6.00K | $4.40K |
You May Also Like
Samuel Backenroth insider profile FAQ
What is the percentage of profitable transactions made by Samuel Backenroth?
The percentage of profitable transactions made by Samuel Backenroth is 0%.
What is the average return per transaction made by Samuel Backenroth?
The average return per transaction made by Samuel Backenroth is -63.40%.
What stocks does Samuel Backenroth hold?
Samuel Backenroth holds: NTBLQ, NBSE stocks.
What was Samuel Backenroth’s latest transaction?
Samuel Backenroth’s latest transaction was an Uninformative Buy of $87.67K.
What was Samuel Backenroth's most profitable transaction?
Samuel Backenroth’s most profitable transaction was an Informative Buy of NBSE stock on May 4, 2020. The return on the trade was -27.20%.
What is Samuel Backenroth's role in Notable Labs?
Samuel Backenroth's role in Notable Labs is Chief Financial Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
